4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001193125-26-454742
Chief Operating Officer gave up 8,889 shares (to pay taxes)
- Chief Operating Officer acquired 31,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hensley Mark Earl Chief Operating Officer | 2026-11-06 | Option exercise | +31,250 | 210,572 | D | ||
| Hensley Mark Earl Chief Operating Officer | 2026-11-06 | Shares withheld for taxes | −8,889 | $0.29 | $2,578 | 201,683 | D |
| Derivatives | |||||||
| Hensley Mark Earl Chief Operating Officer | 2026-11-06 | Option exercise · Restricted Stock Units | −31,250 | 312,500 | D | ||
Loading xslF345X06/ownership.xml…